09-03-2009 Sandoz bestätigt Pionierrolle bei Biosimilars
Sandoz erhält Zulassung für drittes Biosimilar, Filgrastim.
Sandoz Austria
Main options
- Return to Homepage
- Follow this link to skip the site navigation and go straight to the beginning of the content
- Follow this link to skip to the site navigation
- Follow this link to find out more about this site
- Follow this link to find accessibility information and assistance with accessing this site for impaired users
